Fritextsökning
Innehållstyper
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
New management at Øresund
The Øresund University has recently appointed a new director and a new Chairman.
-
Travelling scholarship to DTU professor
The Vera og Carl Johan Michaelsens Rejselegat has the founder of the Medicine and Technology program at DTU with a scholarship.
-
Reidar Rasmussen, Labmodul
Why are you going to Scanlab and Biotech Forum?
-
Gambro varslar 60 anställda
Produktionen av en dialysmaskin modell äldre läggs ned. Den modernare ersättaren kommer att tillverkas utomlands.
-
Integrationsprocessen kan ta upp till sex månader
Konkurrensmyndigheterna ska godkänna Baxters köp av Gambro innan fusionsprocessen kan starta och än är det oklart hur den svenska verksamheten påverkas. "Busine...
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Take off for this year's fair
More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.
-
LEO Pharma - International Clinical Trial Manager
-
From planning stage to handshake
"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...
-
New nanotech professor to DTU
The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.
-
Slemprotein fungerar som bete
Forskare vid Sahlgrenska akademin har identifierat ett protein som kan förklara varför en del människor lättare drabbas av magsår än andra.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Ny kombinationsläsare för mikrotiterplattor
Synergy Mx är en ny multitalang från BioTek som mäter fluorescens, absorbans och luminiscens.
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Exhibitors
Register of exhibitors and where they can be found.
-
Hudceller ger svar om hjärnan
Hudceller kan användas som modeller för att studera transport av ämnen till hjärnan. - Det gör det bland annat betydligt enklare att utveckla och testa nya läke...
-
Enjoy Stockholm - the capital of Scandinavia
Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and at...
-
Grape extract kills cancer cells
Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.
-
Instrument för skräddarsydd behandling snart här
En apparat stor som en mobiltelefon kan komma att revolutionera förskrivningen av läkemedel.
-
CRO-fusion ska ge marknadsfördelar
Amerikansk CRO får tillgång till Europa och europeisk motsvarighet får vice versa i ny sammanslagning.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.